Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

AlgoNomics to enter research collaboration with Genmab
February 2008
SHARING OPTIONS:

GENT, BelgiumóAlgoNomics NV has entered into a research collaboration with Genmab A/S. In the collaboration, AlgoNomics will employ its antibody structure database and Tripole technology to assist Genmab in research related to the structural analysis of Genmab's proprietary antibody scaffolds, including the UniBody technology. Under the agreement, AlgoNomics is eligible for research funding and subsequent potential milestone payments from Genmab. Other financial details and the therapeutic focus of the collaboration were not disclosed.
The research collaboration focuses on the structural properties of fully human antibody and UniBody molecules. Detailed analysis of such structural properties can provide novel insights into their specific function or therapeutic activity. By combining experimental observations with such analyses from AlgoNomics Tripole technology and antibody structure database, it may be possible to further improve on the properties of these antibodies.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.